Indefinite Delivery Contract SPE2DX17D9419

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, awarded under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards across multiple product categories and medical domains. The delivery orders issued under this IDC, valued up to $12,379.22 each, cover the provision of a diverse portfolio of specialized pharmaceuticals, such as Xolair, Trikafta, Keytruda, Botox, and Nucala, as well as standard prescription drugs and medical supplies. Through this contract, DMS Pharmaceutical Group is positioned as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to the Department of Defense's healthcare system.